Clinical guidelines and pharmacist intervention program for HIV-infected patients requiring granulocyte colony-stimulating factor therapy

Pharmacotherapy

Volumn 19, Issue 3, 1999, Pages 356-362

  Engles Horton, Laura L ^a   Skowronski, Carolyn ^a   Mostashari, Farzad ^b   Altice, Frederick L ^b  

^a YALE NEW HAVEN HOSPITAL   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; FLUCYTOSINE; GANCICLOVIR; PYRIMETHAMINE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; STAVUDINE; SULFADIAZINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CLINICAL PHARMACY; CONTROLLED STUDY; DATA BASE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HOSPITAL COST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NEUTROPENIA; PHARMACIST; PRACTICE GUIDELINE; STAFF TRAINING;

EID: 0032983095     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.19.4.356.30938     Document Type: Article

References (18)

1. Richman DD, Fiscl MA, Greico MH, et al. The toxicity of AZT in the treatment of AIDS and ARC. N Engl J Med 1987;317: 192-7.
2. Murphy MF, Metcalfe P, Water AH, et al. Incidence and mechanism of neutropenia and thrombocytopenia in patients with human immunodeficiency virus infection. Br J Haematol 1987;66:337-40.
3. Tracey M, Lai L, Costello C, Clark A. Peripheral blood and bone marrow abnormalities in patients with HIV-related disease. BrJ Haematol 1987;65:289-94.
4. Brettle RP. Bacterial infections in HIV: the extent and nature of the problem. Int J STD AIDS 1997;8(1):5-15.
5. Israel DS, Plaisance KI. Neutropenia in patients infected with human immunodeficiency virus. Clin Pharm 1991;10:268-79.
6. Spruance SL, Pavia AT, Mellors JW, et al. Clinical efficacy of monotherapy with stavudine compared with zidovudine in HIV-infected, zidovudine-experienced patients. A randomized, double-blind, controlled trial. Bristol-Myers Squibb stavudine/019 study group. Ann Intern Med 1997;126(5):355-63.
7. Keiser P, Higgs E, Smith J. Neutropenia is associated with bacteremia in patients infected with the human immunodeficiency virus. Am J Med Sci 1996;312(3}:118-22.
8. Jacobson MA, Stanley HD, Heard SE. Ganciclovir with recombinant methionyl human granulocyte colony-stimulating factor for treatment of cytomegalovirus disease in AIDS patients. AIDS 1992;6:515-17.
9. Van der Wouw PA, van Leeuwen R, van Oers RHJ, Lange JMA. Effects of recombinant human granulocyle colony-stimulating factor on leucopenia in zidovudine-treated patients with AIDS and AIDS related complex, a phase I/II study. Br J Haematol 1991;78:319-24.
10. Moore RD, Keruly JC, Chaisson RE. Neutropenia and bacterial infection in acquired immunodeficiency syndrome. Arch Intern Med 1995;155(18):1965-70.
11. Shaunak S, Bartlett JA. Zidovudine-induced neutropenia: are we too cautious? Lancet 1989;2(8654):91-2.
12. Yim JM, Matuszewiski KA, Vermeulen LC, Ratko TA, Burnett DA, Vlasses PH. Surveillance of colony-stimulating factor use in US academic health centers. Ann Pharmacother 1995;29: 475-81.
13. Perrella O, Finelli E, Perrella A, Tartaglia G, Scognamiglio P, Scalera G. Combined therapy with zidovudine, recombinant granulocyte colony stimulating factors and erythropoietin in asymptomatic HIV patients. J Chemother 1996;8:63-6.
14. Hermans P. Hematopoietic growth factors as supportive therapy in HIV-infected patients. AIDS 1995;9(suppl):S9-14.
15. Mauss S, Steinmetz HT, Willers R, et al. Induction of granulocyte colony-stimulating factor by acute febrile infection but not by neutropenia in HIV-seropositive individuals. J AIDS 1997;14(5}:430-4.
16. Miles SA, Mitsuyasu RT, Moreno J, et al. Combined therapy with recombinant granulocyte colony-stimulating factor and erythropoietin decreases hematologic toxicity from zidovudine. Blood 1991;77:2109-17.
17. Holmes J, Alcabes P, Zampano C, Selwyn P, Friedland GH. Reducing length of stay (LOS) for HIV+ patients at an urban medical center. Presented at the 10th international conference on AIDS and STD, Yokohama Japan, August 7-12, 1994.
18. Hermans P, Rosenbaum W, Jou A, et al. Filgrastim to treat neutropenia and support myelosuppressive medication dosing in HIV infection. G-CSF 92105 study group. AIDS 1996, 10(14):1627-33.